Sadly, there is no cure for Huntington’s disease. But a couple new research papers suggests this may be about to change.

Light physical activity may help lower death risk in cardiovascular-kidney-metabolic syndrome, a condition that includes ...

Biomarkers associated with cognitive impairment differ between men and women with chronic kidney disease, according to data ...

The American College of Cardiology issued its inaugural JACC Cardiovascular Statistics report, highlighting the prevalence of ...

Objective Sjögren’s is a chronic systemic autoimmune disease characterised by dryness symptoms (eyes, mouth, skin), alongside ...

The drug targets a specific mutation that applies to only 2% of ALS patients. A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer’s disease in closely watched trials, drugmaker Novo Nordisk ...

Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral semaglutide failed to slow down Alzheimer's progression Endocrinologist Daniel ...

Nine out of 10 people with chronic kidney disease only find out when it progresses to later stages. Here’s what we know about its risk factors—and why there's new reason to hope for more effective ...

Alzheimer’s disease is a progressive and debilitating condition that slowly robs a person of their memories and personality. Alzheimer’s disease is a form of dementia that produces various symptoms ...